LECTURE series
Do we need high prices to get innovation for small populations?
In this lecture Adrian Towse delves into the intricate world of Orphan Medical Products (OMPs) — therapies meticulously designed for rare diseases that impact small populations.
The central theme of the lecture revolves around the delicate balance between innovation, affordability, and patient well-being within this context.
Adrian explores three critical questions:
- Is Market Exclusivity (ME) needed to incentivise the Research and Development (R&D) of Orphan Medical Products (OMPs)?
- Are R&D costs for individual OMPs lower than those for medicines for more common conditions?
- What is a fair price for OMPs?
Course Le
ssons
Meet the instructor
Adrian Towse
Don't hesitate